查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1347528

药品给药市场：2023-2028 年全球行业趋势、份额、规模、增长、机会和预测

Pharmaceutical Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

市场概况：

2022年，全球药品给药市场规模达到13,250亿美元。展望未来，IMARC集团预计到2028年该市场将达到18,480亿美元，2023-2028年復合年增长率（CAGR）为5.5%。

药物递送是将治疗物质施用到体内的方法。它通过控製药物释放的速率、时间和地点来提高效率、安全性和患者体验。目前，不同类型的药物递送系统可用于释放各种治疗剂。例如，凝胶、脂质体、微球、前药和环糊精是用于肽和蛋白质治疗的有效系统。

药品给药市场趋势：

呼吸道疾病、利甚曼病、中枢神经系统（CNS）和全身性真菌感染等疾病的日益流行是推动市场增长的关键因素之一。此外，老年人口和癌症患者死亡率的显着增加正在刺激对药物给药系统的需求。这些系统增强了抗癌药物的功效并降低了毒性。该市场还受到消费者对个性化和微创 (MI) 医疗治疗倾向的影响。除此之外，由可生物降解聚合物组成的纳米颗粒因增强药物向大脑的输送而越来越受欢迎。它们还协助满足许多国家管理机构对药物输送系统提出的严格要求。这些要求通常包括抵抗雾化过程中产生的力的稳定性、生物相容性、针对肺部的特定位点或细胞群、以预定方式释放药物以及在可接受的时间内降解。据此，研究人员正专注于开发新的药物输送系统，这有助于市场增长。此外，随着全球冠状病毒病（COVID-19）病例激增，对药品的需求增加，预计这将推动市场增长。

本报告回答的关键问题：

  • 迄今为止，全球药物输送市场表现如何，未来几年将如何表现？
  • COVID-19 对全球药品给药市场有何影响？
  • 主要区域市场有哪些？
  • 根据给药途径，市场的分化是什么？
  • 基于应用程序的市场细分是什么？
  • 基于最终用户的市场细分是什么？
  • 行业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球药品给药市场的结构如何？谁是主要参与者？
  • 行业竞争程度如何？

目录

第一章：前言

第 2 章：范围和方法

  • 研究目的
  • 利益相关者
  • 数据源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球药品给药市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按管理途径分類的市场

  • 口服给药
    • 市场走向
    • 市场预测
  • 注射给药
    • 市场走向
    • 市场预测
  • 局部给药
    • 市场走向
    • 市场预测
  • 眼部药物输送
    • 市场走向
    • 市场预测
  • 肺部药物输送
    • 市场走向
    • 市场预测
  • 植入式药物输送
    • 市场走向
    • 市场预测
  • 经粘膜给药
    • 市场走向
    • 市场预测
  • 鼻腔给药
    • 市场走向
    • 市场预测

第 7 章：按应用分類的市场细分

  • 传染性疾病
    • 市场走向
    • 市场预测
  • 癌症
    • 市场走向
    • 市场预测
  • 心血管疾病
    • 市场走向
    • 市场预测
  • 糖尿病
    • 市场走向
    • 市场预测
  • 呼吸疾病
    • 市场走向
    • 市场预测
  • 中枢神经系统疾病
    • 市场走向
    • 市场预测
  • 自身免疫性疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场细分

  • 医院
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 家庭护理设置
    • 市场走向
    • 市场预测
  • 诊断中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场细分

  • 北美
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳大利亚
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉美
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Eli Lilly and Company
    • GSK plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112023A5796

Market Overview:

The global pharmaceutical drug delivery market size reached US$ 1,325 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,848 Billion by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.

Pharmaceutical drug delivery is a method of administering therapeutic substances into the body. It improves efficiency, safety, and patient experience by controlling the rate, time, and place of drug release. At present, different types of drug delivery systems are available for the release of various therapeutic agents. For instance, gels, liposomes, microspheres, prodrugs, and cyclodextrins are among the effective systems used for peptide and protein therapeutics.

Pharmaceutical Drug Delivery Market Trends:

The growing prevalence of diseases, such as respiratory, leishmaniasis, central nervous system (CNS), and systemic fungal infections, represents one of the key factors bolstering the market growth. Moreover, a significant increase in the number of death rates among the older population and individuals who have cancer is catalyzing the demand for pharmaceutical drug delivery systems. These systems provide enhanced efficacy and reduced toxicity for anticancer agents. The market is also influenced by consumer inclination towards personalized and minimally invasive (MI) medical therapy. Apart from this, nanoparticles composed of biodegradable polymers are gaining popularity for enhancing drug delivery to the brain. They also assist in fulfilling the stringent requirements placed on drug delivery systems by governing agencies of numerous countries. These requirements generally include stability against forces generated during aerosolization, biocompatibility, targeting specific sites or cell populations in the lung, drug release in a predetermined manner, and degradation within an acceptable period. In line with this, researchers are focusing on developing new drug delivery systems, which is contributing to market growth. Furthermore, with the surging cases of coronavirus disease (COVID-19) across the globe, there is a rise in the demand for pharmaceutical drugs, which, in turn, is anticipated to fuel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical drug delivery market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on route of administration, application and end user.

Breakup by Route of Administration:

Oral Drug Delivery

Injectable Drug Delivery

Topical Drug Delivery

Ocular Drug Delivery

Pulmonary Drug Delivery

Implantable Drug Delivery

Transmucosal Drug Delivery

Nasal Drug Delivery

Breakup by Application:

Infectious Diseases

Cancer

Cardiovascular Diseases

Diabetes

Respiratory Diseases

Central Nervous System Disorders

Autoimmune Diseases

Others

Breakup by End User:

Hospitals

Ambulatory Surgery Centers

Home Care Settings

Diagnostic Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report:

  • How has the global pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical drug delivery market?
  • What are the key regional markets?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical drug delivery market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Route of Administration

  • 6.1 Oral Drug Delivery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Drug Delivery
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Drug Delivery
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Ocular Drug Delivery
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pulmonary Drug Delivery
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Implantable Drug Delivery
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Transmucosal Drug Delivery
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Nasal Drug Delivery
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Infectious Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diabetes
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Respiratory Diseases
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Central Nervous System Disorders
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Autoimmune Diseases
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Care Settings
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Diagnostic Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 AstraZeneca plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novartis AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Pharmaceutical Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Drug Delivery Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pharmaceutical Drug Delivery Market: Breakup by Route of Administration (in %), 2022
  • Figure 5: Global: Pharmaceutical Drug Delivery Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Pharmaceutical Drug Delivery Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Pharmaceutical Drug Delivery Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Pharmaceutical Drug Delivery (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Pharmaceutical Drug Delivery (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Pharmaceutical Drug Delivery (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Pharmaceutical Drug Delivery (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Pharmaceutical Drug Delivery (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Pharmaceutical Drug Delivery (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Pharmaceutical Drug Delivery (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Pharmaceutical Drug Delivery (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Global: Pharmaceutical Drug Delivery (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Global: Pharmaceutical Drug Delivery (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: North America: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: North America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United States: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United States: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Canada: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Canada: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Asia-Pacific: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Asia-Pacific: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: China: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: China: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Japan: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Japan: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: India: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: India: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: South Korea: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: South Korea: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Australia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Australia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Indonesia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Indonesia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Europe: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Europe: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Germany: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Germany: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: France: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: France: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: United Kingdom: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: United Kingdom: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Italy: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Italy: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Spain: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Spain: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Russia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Russia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Latin America: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Latin America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Brazil: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Brazil: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Mexico: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: Mexico: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 95: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 96: Middle East and Africa: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 97: Middle East and Africa: Pharmaceutical Drug Delivery Market: Breakup by Country (in %), 2022
  • Figure 98: Middle East and Africa: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Global: Pharmaceutical Drug Delivery Industry: SWOT Analysis
  • Figure 100: Global: Pharmaceutical Drug Delivery Industry: Value Chain Analysis
  • Figure 101: Global: Pharmaceutical Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Drug Delivery Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 3: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Pharmaceutical Drug Delivery Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Drug Delivery Market: Key Players